Dulabh Monga
Overview
Explore the profile of Dulabh Monga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah S, Rana T, Kancharla P, Monga D
Cancer Genomics Proteomics
. 2023 Jul;
20(4):398-403.
PMID: 37400141
Background/aim: Pancreatic ductal adenocarcinoma (PDAC) is a malignancy that typically portends a poor prognosis, with a median overall survival ranging from eight to twelve months in patients with metastatic disease....
2.
Ashish S, Raj M, Monga D, Finley G
Cureus
. 2022 Aug;
14(7):e26824.
PMID: 35971344
Fluoropyrimidines (FP's) such as fluorouracil (5-FU) and capecitabine are antimetabolites widely used in many solid tumors. FPs side effects are caused mainly by a lack of dihydropyrimidine dehydrogenase (DPD) enzyme....
3.
Huffman D, Vusqa U, Shankar K, Alnimer L, Samhouri Y, Srinivasamaharaj S, et al.
Cureus
. 2022 Jan;
13(11):e19670.
PMID: 34976460
Background The American Society of Clinical Oncology recommends that patients with advanced cancer receive palliative care services in concurrence with active treatment. While the benefits of palliative care are clear,...
4.
Deyl I, Mohy-Ud-Din N, Cheriyan A, Monga D, Kochhar G
ACG Case Rep J
. 2021 Jul;
8(7):e00606.
PMID: 34250176
Gastrointestinal stromal cell tumors (GISTs) are mesenchymal stromal tumors that are characteristically CD117 positive. Distinction from other spindle cell tumors such as leiomyomas and leiomyosarcomas is based on clinical, histological,...
5.
Barrett C, Park S, Edmondson L, Monga D
J Oncol Pharm Pract
. 2021 Apr;
28(3):577-581.
PMID: 33789524
Objective: This study determined the incidence of hypersensitivity reactions in patients receiving oxaliplatin-based chemotherapy while on H1-receptor antagonists (H1RAs). Prophylaxis for patients receiving oxaliplatin is not currently recommended. H1RAs are...
6.
Rodriguez R, Babar L, Lo H, Ashraf O, Monga D, Finley G, et al.
Cureus
. 2021 Feb;
13(1):e12589.
PMID: 33575150
Purpose This study was conducted to determine factors that influence palliative care (PC) consultation in patients receiving cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Patient and methods We queried...
7.
Chahine Z, Samhouri Y, Jayakrishnan T, Monga D
BMJ Case Rep
. 2020 Oct;
13(10).
PMID: 33051200
A leukemoid reaction is typically defined as white blood cell (WBC) count >50×10/L, predominantly neutrophil precursors, that are not due to tumour involvement in the bone marrow and not derived...
8.
Haag A, Jayakrishnan T, Shah D, Sandhu A, Monga D
Anticancer Res
. 2020 Sep;
40(10):5919-5923.
PMID: 32988923
Background/aim: Early stage extra-pulmonary small cell carcinoma (EPSC) of the esophagus is very rare and is usually treated with chemo-radiation or surgical resection. Case Report: A case of early stage...
9.
Sutera P, Solomina J, Wegner R, Abel S, Monga D, Finley G, et al.
J Gastrointest Cancer
. 2020 Sep;
52(3):976-982.
PMID: 32936391
Background: Standard of care for locally advanced rectal cancer (LARC) (stage II/III) includes preoperative chemoradiation (CRT) followed by resection and adjuvant chemotherapy. Total neoadjuvant therapy (TNT) is a new treatment...
10.
Jayakrishnan T, Bakalov V, Chahine Z, Finley G, Monga D, Wegner R
Cancer Treat Res Commun
. 2020 Aug;
24:100204.
PMID: 32805532
Background: Patients with advanced cancers are among the most vulnerable group of patients. We sought to analyze the impact of Affordable Care Act (ACA) on the interaction of socioeconomic factors...